Aging Clinical and Experimental Research

, Volume 24, Issue 2, pp 113–116 | Cite as

Vascular mild cognitive impairment: concept, definition, and directions for future studies

  • Arturo Consoli
  • Marco Pasi
  • Leonardo Pantoni
Point of view


Vascular mild cognitive impairment (vascular MCI) describes an abnormal condition which is caused by vascular diseases and in which the patient presents with cognitive deficits not severe enough to fit the criteria for dementia (i.e., basic functional autonomy is not lost). As in neurodegenerative MCI, the clinical, neuroimaging, and natural history features of vascular MCI are currently under definition. It is particularly important to identify cognitive impairment of vascular origin during the early stages, as its progression may be slowed or halted by intervening with aggressive treatment of vascular risk factors and diseases. Longitudinal studies on the natural history of vascular MCI, with investigation of the factors responsible for the transition to dementia, are worthy of being planned and carried out.

Key words

Cerebrovascular diseases dementia mild cognitive impairment prevention vascular dementia 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999; 56: 303–8.PubMedCrossRefGoogle Scholar
  2. 2.
    Gauthier S, Reisberg B, Zaudig M et al. Mild cognitive impairment. Lancet 2006; 367: 1262–70.PubMedCrossRefGoogle Scholar
  3. 3.
    Dubois B, Feldman HH, Jacova C et al. Research criteria for the diagnosis of Alzheimer’s disease: revising the NINCDS-ADRDA criteria. Lancet Neurol 2007; 6: 734–46.PubMedCrossRefGoogle Scholar
  4. 4.
    Dubois B, Feldman HH, Jacova C et al. Revising the definition of Alzheimer’s disease: a new lexicon. Lancet Neurol 2010; 9: 1118–27.PubMedCrossRefGoogle Scholar
  5. 5.
    Petersen RC, Stevens JC, Ganguli M et al. Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001; 56: 1133–42.PubMedCrossRefGoogle Scholar
  6. 6.
    Panza F, D’Introno A, Colacicco AM et al. Current epidemiology of mild cognitive impairment and other predementia syndromes. Am J Geriatr Psychiatry 2005; 13: 633–44.PubMedGoogle Scholar
  7. 7.
    Romàn GC, Tatemichi TK., Erkinjuntti T et al. Vascular dementia: diagnostic criteria for research study. Report of the NINDS-AIREN International Workshop. Neurology 1993; 43: 250–60.PubMedCrossRefGoogle Scholar
  8. 8.
    Hachinski VC, Bowler JV. Vascular dementia. Neurology 1993; 43: 2159–60.PubMedCrossRefGoogle Scholar
  9. 9.
    O’Brien JT, Erkinjuntti T, Reisberg B et al. Vascular cognitive impairment. Lancet Neurol 2003; 2: 89–98.PubMedCrossRefGoogle Scholar
  10. 10.
    Rockwood K, Wentzel C, Hachinski V et al. Prevalence and outcomes of vascular cognitive impairment. Vascular Cognitive Impairment Investigators of the Canadian Study of Health and Aging. Neurology 2000; 54: 447–51.PubMedCrossRefGoogle Scholar
  11. 11.
    Pantoni L, Poggesi A, Inzitari D. Cognitive decline and dementia related to cerebrovascular diseases: some evidence and concepts. Cerebrovasc Dis 2009; 27: 191–96.PubMedCrossRefGoogle Scholar
  12. 12.
    Stephan BC, Matthews FE, Khaw KT, Dufouil C, Brayne C. Beyond mild cognitive impairment: vascular cognitive impairment, no dementia (VCIND). Alzheimers Res Ther 2009; 1: 4 (doi:10.1186/alzrt4).PubMedCrossRefGoogle Scholar
  13. 13.
    Erkinjuntti T, Inzitari D, Pantoni L et al. Research criteria for subcortical vascular dementia in clinical trials. J Neural Transm Suppl 2000; 59: 23–30.PubMedGoogle Scholar
  14. 14.
    Frisoni GB, Galluzzi S, Bresciani L, Zanetti O, Geroldi C. Mild cognitive impairment with subcortical vascular features. Clinical characteristics and outcome. J Neurol 2002; 249: 1423–32.PubMedCrossRefGoogle Scholar
  15. 15.
    Luis CA, Barker WW, Loewenstein DA et al. Conversion to dementia among two groups with cognitive impairment. A preliminary report. Dement Geriatr Cogn Disord 2004; 18: 307–13.PubMedCrossRefGoogle Scholar
  16. 16.
    Longstreth WT jr, Manolio TA, Arnold A et al. Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study. Stroke 1996; 27: 1274–82.PubMedCrossRefGoogle Scholar
  17. 17.
    Das RR, Seshadri S, Beiser AS et al. Prevalence and correlates of silent cerebral infarcts in the Framingham Offspring Study. Stroke 2008; 39: 2929–35.PubMedCrossRefGoogle Scholar
  18. 18.
    Wentzel C, Rockwood K, MacKnight C et al. Progression of impairment in patients with vascular cognitive impairment without dementia. Neurology 2001; 157: 714–6.CrossRefGoogle Scholar
  19. 19.
    Ingles JL, Wentzel C, Fisk JD, Rockwood K. Neuropsychological predictors of incident dementia in patients with vascular cognitive impairment, without dementia. Stroke 2002; 33: 1999–2002.PubMedCrossRefGoogle Scholar
  20. 20.
    Pantoni L, Basile AM, Pracucci G et al, on behalf of the LADIS Study Group. Impact of age-related cerebral white matter changes on the transition to disability. The LADIS (Leukoaraiosis And DISability in the elderly) Study: rationale, design and methodology. Neuroepidemiology 2005; 24: 51–62.PubMedCrossRefGoogle Scholar
  21. 21.
    Inzitari D, Pracucci G, Poggesi A et al, for the LADIS Study Group. White matter changes as determinant of global functional decline in elderly independent outpatients. 3-year follow-up of the LADIS (Leukoaraiosis And DISability) Study Cohort. BMJ 2009; 339: b2477. doi:10.1136/bmj.b2477.PubMedCrossRefGoogle Scholar
  22. 22.
    Verdelho A, Madureira S, Moleiro C et al, for the LADIS Study group. White matter changes and diabetes predict cognitive decline in the elderly: the LADIS study. Neurology 2010; 75: 160–7.PubMedCrossRefGoogle Scholar
  23. 23.
    Moorehouse P, Rockwood K. Vascular cognitive impairment: current concepts and clinical developments. Lancet Neurol 2008; 7: 246–55.CrossRefGoogle Scholar
  24. 24.
    Sachdev PS, Chen X, Brodaty H, Thompson C, Altendorf A, Wen W. The determinants and longitudinal course of post-stroke mild cognitive impairment. J Int Neuropsychol Soc 2009; 15: 915–23.PubMedCrossRefGoogle Scholar
  25. 25.
    Stephens S, Kenny RA, Rowan E et al. Association between mild vascular cognitive impairment and impaired activities of daily living in older stroke survivors without dementia. J Am Geriatr Soc 2005; 53: 103–7.PubMedCrossRefGoogle Scholar
  26. 26.
    Waite LM, Grayson DA, Piguet O, Creasey H, Bennett HP, Broe GA. Gait slowing as a predictor of incident dementia: 6-year longitudinal data from the Sydney Older Persons Study. J Neurol Sci 2005; 229–230: 89–93.PubMedCrossRefGoogle Scholar
  27. 27.
    Meyer JS, Quach M, Thornby J, Chowdhury M, Huang J. MRI identifies MCI subtypes: vascular versus neurodegenerative. J Neurol Sci 2005; 229–230: 121–29.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Internal Publishing Switzerland 2012

Authors and Affiliations

  • Arturo Consoli
    • 1
    • 2
  • Marco Pasi
    • 1
    • 2
  • Leonardo Pantoni
    • 1
    • 2
  1. 1.Department of Neurological and Psychiatric SciencesUniversity of FlorenceFirenzeItaly
  2. 2.Stroke Unit and NeurologyAzienda Ospedaliero Universitaria CareggiFirenzeItaly

Personalised recommendations